Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (371-380 of 434) with videos related to

Pageof 44
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2023
The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA-Associated VasculitisJessica L Bloom, Kaci Pickett-Nairn, Lori Silveira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2022
Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3Marta Casal Moura, Gwen E Thompson, Darlene R Nelson, et al.
The Journal of Rheumatology|September 3, 2017
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated VasculitisJoanna C Robson, Gunnar Tomasson, Nataliya Milman, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Annals of the Rheumatic Diseases|September 15, 2012
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitisPaul A Monach, Roscoe L Warner, Gunnar Tomasson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Sophie Hillion, Maximilian F Konig, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 15, 2017
Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesCord H Sunderkötter, Bernhard Zelger, Ko-Ron Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2016
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Veronica J Berrocal, Edward H Giannini, et al.
Arthritis Care & Research|January 26, 2016
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Veronica J Berrocal, Edward H Giannini, et al.
Rheumatology (Oxford, England)|January 18, 2018
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitisDivi Cornec, Brian F Kabat, John R Mills, et al.
Pageof 44

Showing results (371-380 of 434) with videos related to

Sort By:
Pageof 44
Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2023
The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA-Associated VasculitisJessica L Bloom, Kaci Pickett-Nairn, Lori Silveira, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2022
Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3Marta Casal Moura, Gwen E Thompson, Darlene R Nelson, et al.
The Journal of Rheumatology|September 3, 2017
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated VasculitisJoanna C Robson, Gunnar Tomasson, Nataliya Milman, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Annals of the Rheumatic Diseases|September 15, 2012
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitisPaul A Monach, Roscoe L Warner, Gunnar Tomasson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Sophie Hillion, Maximilian F Konig, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 15, 2017
Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesCord H Sunderkötter, Bernhard Zelger, Ko-Ron Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2016
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Veronica J Berrocal, Edward H Giannini, et al.
Arthritis Care & Research|January 26, 2016
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Veronica J Berrocal, Edward H Giannini, et al.
Rheumatology (Oxford, England)|January 18, 2018
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitisDivi Cornec, Brian F Kabat, John R Mills, et al.
Pageof 44